← Oncology Approval Tracker

FDA DECISION ·

Keytruda + chemotherapy

pembrolizumab + platinum-containing chemotherapy · Merck

FDA approvalNew or expanded indicationNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

For resectable NSCLC with tumors at least 4 cm or positive nodes. Give pembrolizumab with platinum chemotherapy before surgery and pembrolizumab alone after surgery.

LAMPGEN ANALYSIS

Why it matters

This decision linked preoperative and postoperative immunotherapy in a single resectable lung cancer strategy.

What research teams should watch

Coordinate systemic treatment, resection and recovery across oncology and thoracic surgery teams.

PRIMARY RECORDS

Sources